Delayed neointimalization on drug-eluting stents - Speculation from optical coherence tomography

Circulation Journal

Volumn 73, Issue 12, 2009, Pages 2210-2211

  Shite, Junya ^a  

^a KOBE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; RAPAMYCIN;

ARTERY INTIMA; DRUG ELUTING STENT; EDITORIAL; HUMAN; INTIMA; INTRAVASCULAR ULTRASOUND; OPTICAL COHERENCE TOMOGRAPHY; REVASCULARIZATION; STENT THROMBOSIS; THROMBOGENESIS; THROMBOSIS PREVENTION;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOVASCULAR AGENTS; CELL PROLIFERATION; CORONARY ANGIOGRAPHY; CORONARY VESSELS; DRUG-ELUTING STENTS; HUMANS; PLATELET AGGREGATION INHIBITORS; RISK ASSESSMENT; RISK FACTORS; SIROLIMUS; THROMBOSIS; TIME FACTORS; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; TUNICA INTIMA;

EID: 73349119081     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-09-0792     Document Type: Editorial

References (9)

1. Kataiwa H, Tanaka A, Kitabata H, Imanishi T, Akasaka T. Safety and usefulness of non-occlusion image acquisition technique for optical coherence tomography. Circ J 2008; 72: 1536-1537.
2. Matsumoto D, Shite J, Shinke T, Otake H, Tanino Y, Ogasawara D, et al. Neointimal coverage of sirolimus-eluting stents at 6-month followup: Evaluated by optical coherence tomography. Eur Heart J 2007; 28: 961-967.
3. Ishigami K, Uemura S, Morikawa Y, Soeda T, Okayama S, Nishida T, et al. Long term follow-up of neointimal coverage of sirolimuseluting stents: Evaluation with optical coherence tomography. Circ J 2009; 73: 2300-2307.
4. Katoh H, Shite J, Shinke T, Matsumoto D, Tanino Y, Ogasawara D, et al. Delayed neointimalization on sirolimus-eluting stents: 6-months and 12-month follow up by optical coherence tomography. Circ J 2009; 73: 1033-1037.
5. Otake H, Shite J, Ako J, Sinke T, Tanino Y, Ogasawara D, et al. Local determinants of thrombus formation following sirolimuseluting stent implantation assessed by optical coherence tomography. J Am Coll Cardiol 2009; 2: 459-466.
6. Finn AV, Joner M, Nakazawa G, Kolodgie F, Newell J, John MC, et al. Pathological correlates of late drug-eluting stent thrombosis: Strut coverage as a marker of endothelialization. Circulation 2007; 115: 2435-2441.
7. Murakami D, Takano M, Yamamoto M, Inami S, Ohba T, Seino Y, et al. Advanced neointimal growth is not associated with a low risk of in-stent thrombus: Optical coherence tomographic findings after first-generation drug-sluting stent implantation. Circ J 2009; 73: 1627-1634.
8. Finn AV, Nakazawa G, Joner M, Kolodgie FD, Mont EK, Gold HK, et al. Vascular response to drug eluting stents: Importance of delayed healing. Arterioscler Thromb Vasc Biol 2007; 27: 1500-1510.
9. Togni M, Windecker S, Cocchia R, Wenaweser P, Cook S, Billinger M, et al. Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction. J Am Coll Cardiol 2005; 46: 231-236.